Will mRNA Technology Companies Spawn Innovation Ecosystems?

Research output: Contribution to journalJournal articleResearch

  • Christoph Grimpe
  • Minssen, Timo
  • William Nicholson Price II
  • Ariel Stern
The mRNA technologies that helped rapidly create effective Covid-19 vaccines could become technology platform businesses, which has tremendous implications for players the world of drug development. These platforms could attract other companies interested in exploiting their advantages to develop other drugs. But all the stakeholders — platform owners, external pharmaceutical and biotech companies, policymakers, and regulators — will have to make a variety of choices.
Original languageEnglish
JournalHarvard Business Review
ISSN0017-8012
Publication statusPublished - 18 Apr 2022

    Research areas

  • Faculty of Law - platform economy, management, Vaccines, regulation, Intellectual property, Open innovation, collaboration

ID: 279498395